DK3044331T3 - Fremgangsmåde til diagnosticering af maligne blodsygdomme samt sæt dertil - Google Patents
Fremgangsmåde til diagnosticering af maligne blodsygdomme samt sæt dertil Download PDFInfo
- Publication number
- DK3044331T3 DK3044331T3 DK14781927.0T DK14781927T DK3044331T3 DK 3044331 T3 DK3044331 T3 DK 3044331T3 DK 14781927 T DK14781927 T DK 14781927T DK 3044331 T3 DK3044331 T3 DK 3044331T3
- Authority
- DK
- Denmark
- Prior art keywords
- diagnostication
- procedure
- methods
- animal blood
- blood diseases
- Prior art date
Links
- 208000014951 hematologic disease Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Testing And Monitoring For Control Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1358721A FR3010530B1 (fr) | 2013-09-11 | 2013-09-11 | Methode de diagnostic des hemopathies malignes et kit associe |
| PCT/FR2014/052255 WO2015036705A1 (fr) | 2013-09-11 | 2014-09-11 | Méthode de diagnostic des hémopathies malignes et kit associé |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3044331T3 true DK3044331T3 (da) | 2020-05-11 |
Family
ID=49551641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14781927.0T DK3044331T3 (da) | 2013-09-11 | 2014-09-11 | Fremgangsmåde til diagnosticering af maligne blodsygdomme samt sæt dertil |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20160319362A1 (da) |
| EP (1) | EP3044331B1 (da) |
| CA (1) | CA2923116C (da) |
| DK (1) | DK3044331T3 (da) |
| ES (1) | ES2788652T3 (da) |
| FR (1) | FR3010530B1 (da) |
| HR (1) | HRP20200747T1 (da) |
| HU (1) | HUE048794T2 (da) |
| PL (1) | PL3044331T3 (da) |
| PT (1) | PT3044331T (da) |
| WO (1) | WO2015036705A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220290242A1 (en) * | 2018-11-05 | 2022-09-15 | Centre Henri Becquerel | Method for diagnosing a cancer and associated kit |
| FR3088077B1 (fr) * | 2018-11-05 | 2023-04-21 | Centre Henri Becquerel | Methode de diagnostic d'un cancer et kit associe |
| CN115315521B (zh) * | 2020-03-31 | 2025-04-18 | 岛津诊断株式会社 | 蜡样芽孢杆菌群检测用培养基 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2347854T5 (es) * | 1996-03-26 | 2014-07-24 | Michael S. Kopreski | Método que permite el uso de RNA extracelular extraído de plasma o suero para detectar, monitorizar o evaluar un cáncer |
| EP1130113A1 (en) | 2000-02-15 | 2001-09-05 | Johannes Petrus Schouten | Multiplex ligation dependent amplification assay |
| US7179598B2 (en) * | 2001-11-20 | 2007-02-20 | The Regents Of The University Of California | Early leukemia diagnostics using microsphere arrays |
| EP1799851A4 (en) * | 2004-08-20 | 2008-04-02 | Univ Manitoba | DIAGNOSTIC OR PROOF METHOD WITH THREE-DIMENSIONAL ANALYSIS |
| JP5433572B2 (ja) * | 2007-07-06 | 2014-03-05 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | Ｍｉｐｏｌ１−ｅｔｖ１遺伝子再編成 |
| AU2008323649A1 (en) * | 2007-11-08 | 2009-05-14 | University Of Washington | DNA microarray based identification and mapping of balanced translocation breakpoints |
-
2013
- 2013-09-11 FR FR1358721A patent/FR3010530B1/fr active Active
-
2014
- 2014-09-11 EP EP14781927.0A patent/EP3044331B1/fr active Active
- 2014-09-11 CA CA2923116A patent/CA2923116C/fr active Active
- 2014-09-11 WO PCT/FR2014/052255 patent/WO2015036705A1/fr not_active Ceased
- 2014-09-11 HU HUE14781927A patent/HUE048794T2/hu unknown
- 2014-09-11 DK DK14781927.0T patent/DK3044331T3/da active
- 2014-09-11 PL PL14781927T patent/PL3044331T3/pl unknown
- 2014-09-11 PT PT147819270T patent/PT3044331T/pt unknown
- 2014-09-11 HR HRP20200747TT patent/HRP20200747T1/hr unknown
- 2014-09-11 US US14/917,087 patent/US20160319362A1/en not_active Abandoned
- 2014-09-11 ES ES14781927T patent/ES2788652T3/es active Active
-
2024
- 2024-06-28 US US18/757,985 patent/US20240417809A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2788652T3 (es) | 2020-10-22 |
| CA2923116A1 (fr) | 2015-03-19 |
| HUE048794T2 (hu) | 2020-08-28 |
| EP3044331B1 (fr) | 2020-03-11 |
| US20240417809A1 (en) | 2024-12-19 |
| FR3010530B1 (fr) | 2015-10-09 |
| FR3010530A1 (fr) | 2015-03-13 |
| PT3044331T (pt) | 2020-05-06 |
| PL3044331T3 (pl) | 2020-10-19 |
| US20160319362A1 (en) | 2016-11-03 |
| HRP20200747T1 (hr) | 2020-10-16 |
| CA2923116C (fr) | 2022-03-29 |
| EP3044331A1 (fr) | 2016-07-20 |
| WO2015036705A1 (fr) | 2015-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL295860B1 (en) | Methods and processes for non-invasive assessment of genetic variations | |
| IL283586A (en) | Methods and processes for non-invasive assessment of genetic variations | |
| DK3024497T3 (da) | Fremgangsmåder og præparater til behandling af hjernesygdomme | |
| PL3353210T3 (pl) | Przeciwciała anty-TIGIT i sposoby stosowania | |
| IL251970B (en) | Anti-cd79b antibodies and methods of use | |
| IL249092A0 (en) | Anti-gitr antibodies and methods of use thereof | |
| DK3041926T3 (da) | Indretning til in-vitro-modellering af in-vivo-væv af organer | |
| EP3177199C0 (en) | MEDICAL DEVICES AND METHODS OF IMPLEMENTING THEM | |
| LT3071046T (lt) | Žirnių baltymų ekstrahavimo būdas | |
| PL3250610T3 (pl) | Przeciwciała anty-FcRn i sposoby ich stosowania | |
| DK3055803T3 (da) | Sporing og analyse af kliniske resultater | |
| DK3083688T3 (da) | Humane anti-cd40 humane antistoffer | |
| HUE051982T2 (hu) | Anti-alfa-szinuklein antitestek és alkalmazási eljárások | |
| IL254670A0 (en) | Humanized anti-c1s antibodies and methods of use thereof | |
| IL242394B (en) | Cenicriviroc compositions and methods of making and using the same | |
| DK3223829T3 (da) | Behandling af sygdomme associeret med hepatisk stellat-celleaktivering under anvendelse af ammoniak-sænkende terapier | |
| CL2016001519A1 (es) | Anticuerpos anti-tau(ps422) humanizados y métodos de utilización | |
| HRP20170840T1 (hr) | Supstituirani ksantini i metode njihove uporabe | |
| DK3240612T3 (da) | Fremgangsmåder til behandling af nethindesygdomme | |
| IL251505A0 (en) | Neuroactive compounds and methods of use thereof | |
| DK3086807T3 (da) | Antistoffer og fremgangsmåder til anvendelse | |
| DK2961378T3 (da) | Fremgangsmåder til behandlingen af mitochondrisk sygdom | |
| HUE050485T2 (hu) | Tauopathia kezelési módszerei | |
| IL247529A0 (en) | Lipoic acid choline ester compositions and methods of use | |
| DK3166628T3 (da) | Terapeutisk anvendelse af knoglemorfogenetiske proteiner |